Drreddys Laboratories | RDY - Umsatzerlöse





Der Umsatz Veränderung Datum
ANI Pharmaceuticals USD 247.06M 19.25M 2025-12
Aurora Cannabis CAD 90.37M 7.65M 2025-09
Bayer EUR 11.44B 1.78B 2025-12
Canopy Growth CAD 66.68M 5.45M 2025-09
Cipla INR 75.18B 710M 2025-12
Corcept Therapeutics USD 202.12M 5.48M 2025-12
Drreddys Laboratories INR 87.27B 1.82B 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Lonza CHF 3.58B 63M 2025-06
Novartis USD 13.91B 144M 2025-09
Pacira USD 196.87M 17.35M 2025-12
Phibro Animal Health USD 373.91M 10.02M 2025-12
Prestige Brands USD 283.44M 9.34M 2025-12
Richter Gedeon HUF 214.69B 26.79B 2025-09
Sun Pharmaceuticals INR 147.99B 3.21B 2025-12
Supernus Pharmaceuticals USD 211.6M 19.5M 2025-12
Teva Pharmaceutical Industries USD 14.63B 10M 2025-12